Experienced in Herpes Simplex Encephalitis

Alexis M. Kalergis

Santiago, RM, CL 
Experienced in Herpes Simplex Encephalitis
Santiago, RM, CL 
OverviewLocationsClinical Research

Overview

Alexis Kalergis practices in Santiago, Chile. Ms. Kalergis is rated as an Experienced expert by MediFind in the treatment of Herpes Simplex Encephalitis. Her top areas of expertise are Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Hypothyroidism, and Oral Herpes.

Her clinical research consists of co-authoring 303 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Herpes Simplex Encephalitis.

Gender
Female

Locations

Santiago, RM, Chile
Other Locations
Chile
Carreras Cortas, ML, Chile

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase Ⅲ, Randomized, Double-blind and Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Individuals Aged 3 Years and Older
A Phase Ⅲ, Randomized, Double-blind and Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Individuals Aged 3 Years and Older
Enrollment Status: Completed
Publish Date: May 28, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of COVID-19 Vaccine(Vero Cell) ,Inactivated in Children and Adolescents Aged 6 Months to 17 Years
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of COVID-19 Vaccine(Vero Cell) ,Inactivated in Children and Adolescents Aged 6 Months to 17 Years
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

303 Total Publications

Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.
Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.
Journal: Current research in microbial sciences
Published: July 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kalergis's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile